Skip to main content
Log in or Sign up
to access My Account functionalities
Find similar products:
-
By ATC code
My Account Area
Find similar products:
-
By ATC code
Report side effect
Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to
site
Back to top
Metaraminol 10mg/ml Solution for Injection or Infusion
Active Ingredient:
Company:
Wockhardt UK Ltd
See contact details
ATC code:
C01CA09
About Medicine
Prescription only medicine
My Account Area
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
Last updated on emc: 09 Oct 2024
Below is a text only representation of the Patient Information Leaflet (ePIL).
The text only version may be available in large print, Braille or audio CD.
For further information call emc accessibility on
0800 198 5000.
The product code(s) for this leaflet is: PL 29831/0740.
Metaraminol 10mg/ml Solution for Injection or Infusion
Package leaflet: Information for the user
Metaraminol 10mg/ml Solution for Injection or Infusion
Metaraminol Tartrate
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
- Keep this leaflet. You may need to read it again.
- A nurse or doctor will give you the injection.
- If you have any further questions, ask your doctor, nurse or pharmacist.
- If you get any side effects, talk to your doctor, nurse or pharmacist.
This includes any possible side effects not listed in this leaflet. See section 4.
What is in this leaflet
1. What Metaraminol is and what it is used for
2. What you need to know before you use Metaraminol
3. How to use Metaraminol
4. Possible side effects
5. How to store Metaraminol
6. Contents of the pack and other information
1. What Metaraminol is and what it is used for
The active substance Metaraminol Tartrate belongs to a group of medicines called vasopressors which work by narrowing the blood vessels causing blood pressure to rise.
It is used to raise low blood pressure to normal levels in an emergency situation.
2. What you need to know before you use Metaraminol
You will be given this medicine in hospital by a doctor or nurse.
Do not use metaraminol
- if you are allergic to metaraminol tartrate or any of the other ingredients of this medicine (listed in section 6)
- with cyclopropane or halothane (anaesthetics) unless your doctor sees a clinical need to do so.
Warnings and precautions
Talk to your doctor, nurse or pharmacist before using metaraminol if you have:
- Liver disease
- Heart disease
- High blood pressure
- Thyroid disease
- Diabetes mellitus
- A history of malaria.
Children
This medicine is not recommended for use in children below the age of 12 years.
Other medicines and metaraminol
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. It is especially important if you are taking:
- Digitalis medicines (such as digoxin) which may cause an irregular heartbeat
- Monoamine oxidase inhibitors which may increase the action of metaraminol.
Pregnancy, breast-feeding and fertility
The effects of this medicine on the unborn baby is unknown. It is not known whether this medicine is present in breast milk. You will only be given this medicine if your doctor sees the clinical need to do so in an emergency situation.
Metaraminol 10mg/ml Solution for Injection or Infusion contains
Sodium metabisulfite - a preservative which may rarely cause severe hypersensitivity reactions and bronchospasm. It may also cause skin reactions if spilt on the skin.
Sodium - contains less than 1mmol sodium (23mg) per 10mg/ml ampoule, that is to say essentially 'sodium - free'.
3. How to use Metaraminol
A nurse or doctor will give you this medicine.
The recommended dose is:
In the case of an emergency, this medicine is given by direct injection into a vein, which may be followed by an infusion into a vein. The dose will be adjusted by your doctor.
The usual dose is between 0.5 - 5mg injected into the vein, followed by an infusion of 15 - 100mg in 500ml Sodium Chloride Injection or Glucose 5% Injection.
Metaraminol 10mg/ml Solution for Injection or Infusion may be used undiluted or diluted.
If you are given more metaraminol than you should use
It is unlikely that you will receive too much because this medicine will be given to you in hospital. You will be carefully monitored by your doctor for symptoms or severely high blood pressure (see symptoms in Section 4 Possible Side Effects).
If you have any further questions on the use of this medicine, ask your doctor or nurse.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Tell your doctor immediately if you experience:
- Sudden itchy rash (hives), swelling of the hands, feet, ankles, face, lips, mouth or throat (which may cause difficulty in swallowing or breathing), feeling that you are going to faint (symptoms of a severe hypersensitivity reaction)
- Pain and/or swelling at the injection site.
The following symptoms may be due to severely high blood pressure. Tell your doctor immediately if you experience:
- Headaches
- High blood pressure (hypertension)
- Slow, or irregular heartbeat
- Shortness of breath
- Feeling sick
- Chest pain
- Abscesses.
Tell your doctor as soon as possible if you experience:
- Cold extremities
- Pain in the extremities.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.
5. How to store Metaraminol
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the label and carton as EXP.
The expiry date refers to the last day of that month. Before use, the doctor or nurse will check the medicine has not passed this date and that the medicine does not show any sign of deterioration.
Do not throw away any medicines via wastewater. These measures will help protect the environment.
Only use this medicine if it is particle free. This medicine is for single use only.
Store below 25°C.
If diluted in a sterile environment, the medicine can be stored for up to 48 hours at ambient temperature 20-22°C or between 2 to 8°C.
6. Contents of the pack and other information
What Metaraminol 10mg/ml Solution for Injection or Infusion contains
The active substance is metaraminol tartrate (1.9 %w/v), which is equivalent to 1.0 %w/v (10mg/ml) metaraminol.
The other ingredients are: sodium chloride, sodium metabisulfite (E223) and water for injections.
May contain traces of sodium hydroxide or hydrochloric acid (for pH adjustment).
What Metaraminol 10mg/ml Solution for Injection or Infusion looks like and contents of the pack
This medicine is a clear, colourless solution free of particles.
It is available in a 1 ml clear glass ampoules with a purple coloured spot and one-point-cut score, packed into cartons containing 10 ampoules.
Marketing Authorisation Holder:
Wockhardt UK Ltd
Ash Road North
Wrexham
LL13 9UF
UK
Ash Road North
Wrexham
LL13 9UF
UK
Manufacturer:
CP Pharmaceuticals Ltd
Ash Road North
Wrexham
LL13 9UF
UK
Ash Road North
Wrexham
LL13 9UF
UK
Other formats
To listen to or request a copy of this leaflet in Braille, large print or audio please call, free of charge: 0800 198 5000 (UK only). Please be ready to give the following information:
Product name Reference number
Metaraminol 10mg/ml Solution for Injection or Infusion PL 29831/0740
This is a service provided by the Royal National Institute of Blind People.
This leaflet was last revised in 03/2024
108609/2
Wockhardt UK Ltd
Address
Ash Road North, Wrexham Industrial Estate, Wrexham, LL13 9UF
Telephone
+44 (0)1978 661 261
Fax
+44 (0)1978 661 702
Medical Information e-mail
[email protected]
Delivered to you by
